Bansisons Tea Industries Ltd — Important, 19-11-2025: Company Update
19-11-2025 | 04:23 pm
19-11-2025 | 04:23 pm
Bansisons Tea Industries Limited's Board has approved a significant strategic overhaul, signaling a potential shift in its core business. The company proposes to amend its Object Clause and change its name to either "Quantum Care Pharmachem Limited" or "Novyra Pharmachem Limited," subject to MCA approval. Furthermore, the board approved the sale of company land. These key proposals, which would redefine the company's future direction, await shareholder approval through a postal ballot. Separately, an Independent Director has resigned from the board due to pre-occupation.
No comments yet. Be the first to comment!
